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Background: The comparability of gene expression between blood and brain tissues is a central issue in
neuropsychiatric research where the analysis of molecular mechanisms in the brain is of high importance for the
understanding of the diseases and the discovery of biomarkers. However, the accessibility of brain tissue is limited.
Therefore, knowledge about how easily accessible peripheral tissue, e. g. blood, is comparable to and reflects gene
expression of brain regions will help to advance neuropsychiatric research.
Description: Gene expression in the blood, hippocampus (HC) and prefrontal cortex (PFC) of genetically identical
rats was compared using a genome-wide Affymetrix gene expression microarray covering 29,215 expressed genes.
A total of 56.8% of 15,717 expressed genes were co-expressed in blood and at least one brain tissue, while 55.3% of
all genes were co-expressed in all three tissues simultaneously. The overlapping genes included a set of genes of
relevance to neuropsychiatric diseases, in particular bipolar disorder, schizophrenia and alcohol addiction. These
genes included CLOCK, COMT, FAAH, NPY, NR3C1, NRGN, PBRM1, TCF4, and SYNE.
Conclusions: This study provides baseline data on absolute gene expression and differences between gene
expression in the blood, HC and PFC brain tissue of genetically identical rats. The present data represents a valuable
resource for future studies as it might be used for first information on gene expression levels of genes of interest in
blood and brain under baseline conditions. Limitations of our study comprise possible contamination of brain tissue
with blood and the non-detection of genes with very low expression levels. Genes that are more highly expressed
in the brain than in the blood are of particular interest since changes in their expression, e.g. due to disease status,
or treatment, are likely to be detected in an experiment. In contrast, genes with higher expression in the blood than
in the brain are less informative since their higher baseline levels could superimpose variation in brain.
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The pathogenesis of neuropsychiatric diseases still re-
mains poorly understood. Although genome-wide asso-
ciation studies have generated robust evidence for the
involvement of various of genes in a number of psychi-
atric disorders (for a review see: Sullivan et al. 2012) the
underlying molecular mechanisms are still await clarifi-
cation (Schulze 2010). Identification of the biological
factors that underlie these diseases is difficult since it re-
quires observation of biological processes such as gene-* Correspondence: stephanie.witt@zi-mannheim.de
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are difficult to access.
A useful approach to the identification of the molecu-
lar mechanisms implicated in the etiology and under-
lying processes of neuropsychiatric disease is to study
genes that are differentially expressed during illness
phases and well-being or between patients and healthy
controls. This provides an important tool for discovering
molecular mechanisms which are involved in disease
etiology and disease processes. However, due to the in-
accessibility of brain tissue, most gene expression studies
involve either post-mortem brain samples or readily ob-
tainable peripheral tissue, in particular blood. The ques-
tion therefore arises, as to whether and to what extentopen access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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rable to gene expression in the brain.
To date, few studies have addressed these important
questions. In 2006, Sullivan et al. compared transcripts
in human blood and post-mortem brain and found a
median non-parametric correlation between transcripts
present in both whole blood and the central nervous
system (CNS) of around 0.5. The authors suggested that
the use of peripheral gene expression may be a useful
surrogate for gene expression in the brain, provided that
the genes of interest are definitely expressed in both
types of tissue (Sullivan et al. 2006). However, this study
involved random human blood and CNS samples. The
heterogeneity of genetic background in humans and the
general methodological problems associated with the use
of post-mortem brain samples therefore limit the in-
terpretability and applicability of these results. Sullivan
et al. concluded that animal studies would be informa-
tive (Sullivan et al. 2006). Peripheral blood mononuclear
cell (PBMC) profiles showed co-expression levels of
summarized transcripts for 4,103 of 17,859 (22.9%) tran-
scripts and rat hemi-brain and 19% of transcripts blood
showed similar expression. However, at the time of writ-
ing, no comprehensive reference database for absolute
gene expression levels in the blood and specific brain re-
gions of animals is available.
In a study with vervet monkeys, gene expression pro-
files in eight brain tissues and blood of 12 vervet mon-
keys was analyzed (Jasinska et al. 2009). The focus of
this study was to find high inter- and intraindividual
brain gene expression differences displayed in the blood
to identify candidate genes for mapping brain eQTL in
peripheral blood. They find a co-expression of 2,430
genes over all tissues and blood in twelve animals. How-
ever, in comparison to age matched inbred rat strains,
results are confounded by a high interindividual hetero-
geneity and more imprinting. Moreover, vervets are not
a feasible animal model for challenging experiments.
Challenging – e.g. by alcohol consumption – would be a
necessary intervention to analyse how changes in brain
gene expression are reflected in the blood.
In our study, we analyzed gene expression profiles of
genetically identical rats in blood, hippocampus and pre-
frontal cortex in order to assess baseline values of con-
cordant and differential gene expression between these
tissues. We chose to collect these data in animal models
to avoid confounding factors which usually limit the in-
terpretability of data from humans.
Construction and content
Blood and tissue sampling, and RNA preparation
Four male 6-week old Wistar rats (Charles River, Sulzfeld,
Germany), were housed for 1 week under standard condi-
tions (2 per cage, 12-h artificial light–dark cycle, lights on7:00, temperature: 22° ± 1°C, humidity: 55% ± 5%, food
and water ad libitum). Animals were sacrificed by decapi-
tation (around 10 am). Blood samples were immediately
collected in PAXgene tubes containing a stabilizing agent
for RNA (Preanalytix, BD) and rat brains were quickly re-
moved, submerged for 3 minutes in −40°C isopentane
(Sigma-Aldrich Co., St. Louis, Missouri). All samples were
stored at −80°C. For dissection, brains were sliced in co-
ronal sections of 120 μm in a Leica CM3000 Cryostat
(Leica, Bensheim, Germany). PFC and HC tissues were
punched out, collected into vials and stored at −80°C. For
RNA isolation, punched tissue were lysed in TRIzol® Rea-
gent (Invitrogen, Karlsruhe, Germany) and homogenized
by passing the suspension 30 times through a 22-gauge
needle. Total RNA was extracted by adding chloroform.
To achieve better separation of organic and aqueous
phases, Phase Lock Gel™ Heavy tubes (Eppendorf, Ham-
burg, Germany) were used. Upper phases were carefully
removed by pipetting and total RNA was purified using
RNeasy® Micro Kit (Qiagen, Hilden, Germany). RNA from
blood samples was isolated with PAXgene Blood RNA Kit
50 (PreAnalytiX, Qiagen) according to the manufactures
recommendation. Total RNA yield was determined with
Quant-iT™ RiboGreen® RNA Reagent and Kit (Invitrogen)
by measuring in a Wallac Victor 2 1420 Multilabel Counter
(Perkin Elmer, Jügesheim, Germany). Total RNA purity
was evaluated by OD measurements (260 nm/280 nm) in
a NanoDrop (peqLab, Erlangen, Germany) and its in-
tegrity was determined by RNA integrity number (RIN)
measurement using RNA 6000 Nano Assay RNA chips
run in an Agilent 2100 Bioanalyzer (Agilent Technologies,
Palo Alto, CA). Ratios of 1.9–2.2 (OD 260/280) and
RIN > 8.0 as well as an absence of a peak of genomic
DNA contamination in electropherograms were chosen as
inclusion criteria.
Microarry processing and statistical analysis
Gene expression profiling was performed using GeneChip
Rat Gene 1.0 ST Array (Affymetrix, Inc., Santa Clara, CA,
USA). Samples were transcribed to cDNA and hybri-
dized to Affymetrix GeneChip Rat Gene 1.0 ST Array
(Affymetrix, Inc., Santa Clara, CA) per the Whole
Transcript (WT) Sense Target Labeling Assay proto-
col [Affymetrix 2006] using 200 ng of total RNA from
each sample. The raw fluorescence intensity values were
imported, quantile normalized and RMA transformed
using the affymetrix power tools (apt-1.51). To define a
transcript/gene as detected, the dabg (Detected Above
Background) p-values were calculated with apt-program.
It calculates the p-value that the intensities in a probeset
could have observed by chance in a background distri-
bution. When the dabg-p-value was smaller or equal
than 0.05 and the mean of all three RMA-intensities
were higher than 6.2 (the overall mean of all probeset-




















Blood all 10,529 67.0 100
Blood only 1,598 10.2 - 15.2
Brain all 14,119 89.8
PFC all 13,708 87.2 -
PFC only 283 1.8 - 2.1
HC all 13,734 87.4 -
HC only 279 1.8 - 2.0
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sample did not pass the quality criteria and was omitted
from the analysis.
Analysis of genes implicated in psychiatric diseases
The gene expression data was analyzed with respect to
the presence of a selection of genes that have been de-
scribed to be relevant for psychiatric diseases, especially
bipolar disorder, schizophrenia and alcohol addiction
(Chen et al. 2013; Green et al. 2013; Hodgkinson et al.
2008; Lee et al. 2012; McMahon et al. 2010; Mitchell
and Porteous 2011; Schizophrenia Psychiatric Genome-
Wide Association Study C 2011; Shi et al. 2011; Stefansson
et al. 2009; Steinberg et al. 2011; Vassos et al. 2012).
Absolute gene expression in blood, PFC and HC
Figure 1 (Venn diagram) shows the absolute number of
expressed genes found in blood, PFC and HC. Table 1
depicts number and percentages of total expressed genes
and of the overlap in the different tissues (cut-off level
of 6.2 for all data and present in all samples p < 0.05).
All raw and normalized data have been deposited in the
Gene-expression Omnibus database (http://www.ncbi.
nlm.nih.gov/geo/; accession number GSE49352).
Of the 29,215 probe sets from the Rat Gene 1.0 ST
Array read into jmp genomics, the total number and
percentage of expressed genes at a cut-off level of 6.2 in
all investigated tissues (blood, PFC and HC) is 15,717
(53.8%). Of these genes, 10,529 (67.0%) are expressed in
blood, 13.708 (87.2%) in PFC, and 13,734 (87.4%) in HC
respectively.Figure 1 Venn diagramm: absolute number of expressed genes
found in blood, PFC and HC.Of all genes that are expressed in the blood, 8,931
(84.8%) are also expressed in at least one brain tissue
(Table 1 and Figure 1). 8,697 (82.6%) of blood-expressed
genes are expressed in both PFC and HC.
1,598 (10.2%) of the detected mRNAs are detected ex-
clusively in the blood, whereas 4,626 (29.4%) transcripts
are only detectable in both PFC and HC. Another 562
(3.6%) genes are expressed in either PFC or HC only
adding up to a total number of 5,188 (33.0%) of exclu-
sively brain-expressed genes.
Comparison of genes implicated in psychiatric diseases
The comparison of genes implicated in psychiatric disor-
ders revealed a set of genes that is co-expressed in
blood, PFC and HC (Figure 2).
Utility
The issue of comparability of gene expression in the
blood and the brain is crucial for studies of psychiatric
disorders where access to brain tissue is limited. In using
blood as a substitute for brain tissue, knowledge of both
the degree of overlap in and the tissue-specificity of gene
expression is crucial.
The present study provides a baseline data concer-
ning absolute gene expression and differences in gene
Figure 2 Selection of formerly described bipolar disorder,
schizophrenia and alcohol addiction genes, which are present
as expressed transcripts according to more than one tissue
type. Depicted are absolute expression levels of individual animals.
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in genetically identical rats. The present data represents
a valuable resource for future studies as it might be used
for information on gene expression levels of genes of
interest in blood and brain under baseline conditions.
A large number of genes were co-expressed in blood
and brain tissue, and approximately 60% of genes blood-
expressed were also present in at least one brain region.
Congruent with the results of Jasinska et al. (2009), in
the present study, housekeeping genes presented a large
portion of overlapping expressed genes. For 59% of co-
expressed genes, gene expression was higher in the brain
than in the blood. This group of genes is especially in-
formative since changes in their expression, e.g. due to
disease status, or treatment, are likely to be detected in
an experiment. In contrast, genes with higher expression
in the blood than in the brain are less informative since
their higher baseline levels could superimpose variation
in brain.
As expected, a number of genes were co-expressed in
blood and one brain region only. Information on co-
expressed genes that are specific to blood and a single
brain region allows to relate blood gene expression
changes to different regions in the brain.
The brain regions analyzed in the present study, i.e.
the PFC and HC - are very different in terms of both,
function and structure. Nevertheless, a large number of
genes were expressed in both tissues and only a small
subset that is specific for a single brain region. Although
the group of brain region specific genes is small, re-
search has shown that differences between brain regions
are the most important source of variance in quantita-
tive assessments of expression profiles (Matthaus et al.
2009; Reimers et al. 2005). Genes with overlapping ex-
pression in blood and brain included a set of genes
which of relevance for psychiatric diseases, in particular
bipolar disorder, schizophrenia and alcohol addiction
(Chen et al. 2013; Green et al. 2013; Hodgkinson et al.
2008; Lee et al. 2012; McMahon et al. 2010; Mitchell
and Porteous 2011; Schizophrenia Psychiatric Genome-
Wide Association Study C 2011; Shi et al. 2011; Stefansson
et al. 2009; Steinberg et al. 2011; Vassos et al. 2012). These
include CLOCK, COMT, FAAH, NPY, NR3C1, NRGN,
PBRM1, TCF4, and SYNE (Figure 2).
Discussion
The aim of this study was to compare blood and brain
gene expression levels in the same animal at the same
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the collection of biomaterial. To optimize this approach,
genetically identical rats were chosen for analysis. The
advantage of this approach is that it ensured a high de-
gree of homogeneity in terms environmental conditions.
A shortcoming of the approach is that differences in
gene expression exist in rats compared to humans.
Moreover, the low number of samples precluded any
analysis of quantitative differences.
A promising strategy for future studies, it would be
desirable to be able to compare blood and brain gene ex-
pression in humans, e.g. of material which is collected
during brain surgery. Even during scrupulous biomate-
rial collection, the possibility of contamination of brain
tissue with blood cannot be entirely exluded. Therefore,
some of the genes co-expressed in blood and brain are
due to this contamination. However, blood contami-
nation should lead to only very low levels of gene ex-
pression that should lie below the applied cut-off level.
Moreover, there is a number of genes exclusively ex-
pressed in the brain (33.0%, Table 1) suggesting that the
level of contamination of the brain expression profiles by
blood specific transcripts was low.
Gene expression varies widely across different brain
regions (Hansson et al. 2006). Therefore, in future stu-
dies, analysis of the co-expression of genes in blood and
brain regions other than the HC and PCF would be of
interest.
Furthermore, since miRNAs are also of interest in psy-
chiatric research, data concerning the comparability of
miRNAs levels in the blood and in brain would be desi-
rable (Tapocik et al. 2013).
The present analysis generated data on baseline gene
expression levels in wild-type rats. Gene expression ana-
lyses in the blood and brain of rats which have under-
gone some form of challenge or which differ in disease
state would also be of interest since they would facilitate
the elucidation of if and how changes of brain gene ex-
pression might be reflected in blood.Conclusion
Knowledge of the comparability of gene expression in
blood and brain is an important issue in neuropsy-
chiatric research. Although further aspects need to be
addressed, the present study is the first to provide a sys-
tematic analysis of absolute gene expression levels in
blood and single brain regions. Genes higher expressed
in the brain than in blood are of particular interest since
changes in gene expression in this readily accessible tis-
sue may reflect disease status, or treatment.Competing interests
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